163 related articles for article (PubMed ID: 20828645)
1. The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.
Stone PH; Chaitman BR; Stocke K; Sano J; DeVault A; Koch GG
J Am Coll Cardiol; 2010 Sep; 56(12):934-42. PubMed ID: 20828645
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
3. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine and its anti-ischemic effects: revisiting an old mechanistic paradigm anew?
Boden WE
J Am Coll Cardiol; 2010 Sep; 56(12):943-5. PubMed ID: 20828646
[No Abstract] [Full Text] [Related]
5. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Mega JL; Hochman JS; Scirica BM; Murphy SA; Sloan S; McCabe CH; Merlini P; Morrow DA
Circulation; 2010 Apr; 121(16):1809-17. PubMed ID: 20385930
[TBL] [Abstract][Full Text] [Related]
8. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
[TBL] [Abstract][Full Text] [Related]
10. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
Koren MJ; Crager MR; Sweeney M
J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcium antagonists on exercise tests.
Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
[TBL] [Abstract][Full Text] [Related]
14. Effect of losartan in treatment of exercise-induced myocardial ischemia.
Longobardi G; Corbi G; Cacciatore F; Abete P; Furgi G; Vitale DF; Rengo F; Ferrara N
Am J Cardiol; 2007 Nov; 100(10):1517-21. PubMed ID: 17996511
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
16. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
[TBL] [Abstract][Full Text] [Related]
17. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
Grönefeld G; Bernhardt J; Schneider W
Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
19. Enhanced glucose oxidation in exercise-induced myocardial ischemia.
Montague T; DeAlmeida J; Lopaschuk G; Witkowski F; Walker D; Ackman M; Humen D; Dzavik V; Teo K
Can J Cardiol; 1994 Nov; 10(9):913-9. PubMed ID: 7954027
[TBL] [Abstract][Full Text] [Related]
20. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]